In routine clinical practice,few physicians use early viral kinetics to guide HCV dual therapy treatment decisions期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

In routine clinical practice,few physicians use early viral kinetics to guide HCV dual therapy treatment decisions

Authors:	Alessandra Mangia Tivadar Bányai Giuseppe De Bartolomeo Judit Gervain François Habersetzer Jean‐Pierre Mulkay Denis Ouzan Giustino Parruti Nicola Passariello Andre‐Jean Remy Mario Rizzetto Mitchell L. Shiffman Manuela Schmitz Fernando Tatsch Maribel Rodriguez‐Torres

Affiliation:	1. Liver Unit, IRCCS Hospital ‘Casa Sollievo della Sofferenza’, , San Giovanni Rotondo, Italy;2. Department of Infectology, Pándy Kálmán Hospital, , Gyula, Hungary;3. Internal Medicine Liver Unit Hospital, F. Veneziale, , Isernia, Italy;4. Department of Internal Medicine/Hepatology and Molecular Diagnostic laboratories, Szent Gyorgy Hospital, , Székesfehérvár, Hungary;5. P?le Hépato‐digestif, Inserm 1110, Université de Strasbourg, Nouvel H?pital Civil, , Strasbourg, France;6. Hepato‐gastroenterology, CHU Saint‐Pierre, , Brussels, Belgium;7. Institut Arnault Tzanck, , Saint‐Laurent‐du‐Var, France;8. Infectious Disease Unit, Santo Spirito General Hospital, , Pescara, Italy;9. Department of Geriatrics and Metabolic Diseases, University of Naples, , Naples, Italy;10. Centre Hospitalier de Perpignan, , Perpignan, France;11. University of Turin, , Turin, Italy;12. Liver Institute of Virginia, Bon Secours Health System, , Richmond and Newport News, VA, USA;13. IST GmbH, , Mannheim, Germany;14. F. Hoffmann‐La Roche Ltd, , Basel, Switzerland;15. Fundación de Investigación, , San Juan, PR, USA

Abstract:

Keywords:	abbreviated therapy clinical practice hepatitis C peginterferon alfa/ribavirin physician behaviour PROPHESYS ribavirin dose treatment decisions viral kinetics

设为首页 | 免责声明 | 关于勤云 | 加入收藏